A famous Korean screenwriter steps back — and an industry looks at itself
In South Korea, where television dramas can shape national conversation, launch stars and travel globally through streaming platforms, a statement from a single writer can land like breaking news. That is what happened when Im Sung-han, one of the country’s most recognizable and polarizing television writers, said she may take a break from drama writing for several years after finishing her current series, “Doctor Shin.”
For American audiences, it may help to think of Im as the kind of creator whose name alone can sell a show — someone closer to a brand than simply a staff writer. In the United States, TV is often discussed through showrunners such as Shonda Rhimes, Taylor Sheridan or Ryan Murphy. In South Korea, individual writers have long held an unusually visible and powerful place in the television ecosystem, especially in melodrama and family serials. Their signatures matter. Their quirks matter. Their fan bases matter. And when one of the biggest names says the work itself has become physically damaging, people pay attention.
Im made the remarks in a phone interview with a YouTube channel, saying that writing dramas is so taxing that she is considering a multi-year hiatus. She also floated the possibility of moving into health-focused entertainment programming instead. The timing is significant. Her current TV Chosun series, “Doctor Shin,” has struggled in the ratings, hovering around the low single digits, according to Korean media accounts. But the real importance of her comments is not whether one drama underperformed. It is what her fatigue reveals about the economics, creative pressure and human cost of the Korean drama machine.
For more than three decades, Im has occupied a singular space in Korean pop culture: provocative, commercially potent and often divisive. Since debuting in 1990, she has built a career on stories that inspire both loyalty and backlash. Her work has often been described as addictive by fans and excessive by critics. That split reaction is not incidental; it is central to her public identity. So when a writer like that says she can no longer treat the next drama as the obvious next step, the story becomes larger than one career decision. It turns into a question about what Korean television now demands of the people who make it.
“Doctor Shin” and the limits of ratings as a verdict
On paper, “Doctor Shin” sounded like the kind of swing that could renew a veteran career. The series centers on a genius doctor, Shin Ju-shin, and a character named Momo, whose damaged brain leaves her slipping away from her own soul. It was billed as a medical thriller, a new genre challenge for Im, who is more commonly associated with relationship-driven drama and emotionally heightened family storytelling. Before the show aired, that departure alone generated attention. Viewers familiar with her earlier work were curious to see what would happen when a writer known for outrageous turns and emotional extremity moved into a genre that usually depends on procedural logic and tension.
The result, by all indications, has been mixed. Some viewers appear to have embraced the show’s audacity. Others seem to have balked at its more extreme conceits, including a so-called “brain change surgery” plot device that foregrounds shock value over realism. That kind of storytelling is not unusual in Korean drama, where heightened setups are often part of the appeal. But there is a difference between melodramatic flourish and a premise so radical that it raises the barrier to entry for casual viewers. In a crowded media market, especially one where audiences can leave a series after ten minutes and switch to Netflix, YouTube or a rival broadcast drama, that barrier matters.
Im, notably, has shown little interest in accepting ratings as the only meaningful scorecard. In comments reported by Korean outlets, she suggested that if a show were truly poor and not entertaining, that would be worth regretting. But if viewers who do connect with it say they are absorbed and enjoying it, that has value on its own. She also expressed confidence that the show improves as it goes. That stance may sound defensive, but it also points to a real fault line in television today: the widening gap between numerical performance and cultural life.
American viewers know this argument well. Plenty of series in the United States have posted modest linear ratings while thriving in streaming, building cult followings or gaining retrospective respect. Shows like “Friday Night Lights” and “Crazy Ex-Girlfriend” never dominated by raw numbers alone, yet each left a lasting imprint because of the intensity of audience attachment. The Korean market is different, but the broader tension is familiar. A single ratings number may still drive ad sales, scheduling decisions and headlines, but it does not fully capture staying power, fandom density or the possibility that a show may later be reevaluated more generously than it was in real time.
That is especially true for a writer like Im. Her work has rarely lived in the safe middle. It tends to provoke strong reactions, which means it can be easy to dismiss in the moment and harder to forget over time. If “Doctor Shin” has underperformed by conventional broadcast standards, that may say something about its accessibility, platform fit or timing. It does not automatically settle the question of whether the series has creative force, or whether Im’s brand of storytelling still exerts a pull on viewers who are willing to meet it on its own terms.
In South Korea, the writer is not just a writer
To understand why Im’s remarks carry unusual weight, it helps to understand the status of TV writers in South Korea. In Hollywood, the term “showrunner” usually implies an executive producer who oversees the writers room, production decisions and the broader creative direction of a series. South Korea has historically worked differently. While directors and production companies matter, the writer can be the central authorial figure in a way that often feels more literary than industrial. Some of the country’s most famous dramas are associated first with their writers, not their directors.
That system has produced some of the biggest hits in Korean television history. It has also created intense pressure around so-called “star writers,” a term widely used in South Korea to describe elite, high-profile creators whose names attract financing, viewers and major actors. These writers are expected not just to deliver scripts, but to deliver a worldview, a tone and a kind of event television. When they succeed, they are treated like hitmakers. When they stumble, the blowback is personal and swift.
Im belongs firmly in that category. She has long been the kind of writer whose casting choices, plot twists and even narrative excesses become their own mini-news cycle. In a media culture that prizes novelty and fast reaction, that has made her both influential and vulnerable. A star writer can command unusual authority, but that authority comes with unusual exposure. Every episode becomes a referendum not just on the show, but on the writer’s instincts, relevance and staying power.
That may sound glamorous from the outside, but it also means the Korean drama system can place extraordinary creative weight on one person. The expectations are not simply that a writer deliver scripts on deadline. The writer must preserve a franchise-like identity, satisfy loyal viewers, attract new ones, absorb criticism and often sustain production under punishing time constraints. In that environment, even success can be exhausting. Failure, or even the perception of underperformance, can make the pressure feel all-consuming.
Im’s statement that drama writing is harmful to her health is striking partly because it cuts through the mythology that great television comes from relentless endurance. In many entertainment industries, burnout is still treated as an unfortunate but normal byproduct of excellence. South Korea is hardly alone in that. But Korean drama production has long been associated with compressed timelines, last-minute script changes and a pace that can leave little room for recovery. The romantic image of the tireless creator grinding through the night has become harder to defend in an era when more artists are openly discussing physical and mental limits.
Burnout is not a private weakness. It is a structural warning.
The most important line in this story may be the simplest one: that writing dramas is bad for her health. That is not just a confession. It is an indictment of a system.
South Korea’s drama industry has transformed dramatically over the past decade. Korean series are now exported at a scale that would have been hard to imagine a generation ago. Netflix helped accelerate that global reach, but it did not create the intense production culture that underpins it. Long before “Squid Game” became a worldwide phenomenon, Korean television was already built on speed, volume and fierce competition. Broadcasters, cable channels, newer general programming networks and streaming platforms all compete for attention in a marketplace where novelty is constant and audience patience is thin.
In that system, the hidden costs often fall on creators and crews. Writers, in particular, can be asked to function as inexhaustible engines of originality. If a series depends on a specific voice, there may be little practical relief when deadlines tighten. The writer becomes both auteur and bottleneck. That may help preserve a distinctive style, but it also creates fragility. If one person is carrying too much of the creative load, then the sustainability of the entire production can hinge on one individual’s stamina.
American readers may recognize echoes of this from recurring debates in Hollywood over overwork, “crunch” and the pressures of content demand in the streaming era. The details differ, but the core problem is recognizable: industries built around constant output often treat human exhaustion as a scheduling problem rather than a warning sign. Im’s remarks suggest that in Korean drama, the issue has become impossible to ignore. If a writer with her stature is openly contemplating years away from the field, then the problem is no longer anecdotal.
Her suggestion that she might instead explore a health-themed variety program is also revealing. In Korea, variety shows — a broad category that can include talk formats, reality competitions, travel programs and lifestyle content — often operate under a different creative rhythm than scripted drama. They can still be demanding, but they usually do not require the same kind of sustained narrative construction episode after episode. There is symbolism in the idea that a writer known for high-intensity fictional worlds is now drawn to a genre centered on wellness, balance and the body itself. It suggests a pivot away from escalation and toward survival.
That shift speaks to something broader in Korean culture as well. South Korea is often admired abroad for its speed: fast internet, fast consumer trends, fast pop-cultural turnover. But that speed has a cost. Conversations about overwork, burnout and the pressure to perform have grown louder across Korean society, from schools to offices to entertainment. Im’s comments fit into that wider national reckoning. What she is describing is not only artistic fatigue. It is the strain of a system that rewards constant reinvention while leaving limited space for recovery.
Has the era of the star writer ended? Not exactly.
One way to read the “Doctor Shin” story is as evidence that the old order is fading. A writer once powerful enough to generate headlines simply by attaching her name to a project now launches an ambitious new show and fails to turn that notoriety into a major ratings win. The market has changed. Viewers are fragmented. Platforms are multiplying. Prestige no longer lives in just one place. By that logic, the star writer as Korea once knew the figure may be losing power.
There is truth in that, but only up to a point. It is more accurate to say the role is being reorganized, not erased. Name recognition still matters. In a cluttered media environment, a familiar creative voice can be one of the few reliable ways to cut through the noise. What has changed is that reputation alone no longer guarantees durable attention. A big-name writer may still deliver a strong opening signal, but retention now depends on far more variables: pacing, genre precision, meme-ability, platform strategy, social media response and the habits of viewers who increasingly watch on their own schedule rather than in lockstep with a broadcaster.
That shift is not unique to South Korea. American television has also moved from an era of appointment viewing toward a fractured landscape in which audiences can sample endlessly and commit rarely. In that environment, creators with strong brands are still valuable, but they must now balance artistic identity with accessibility in a much more competitive field. The same appears true in Korea. A writer like Im can still command attention, but she has to compete not only with other Korean dramas in the same time slot, but with global streaming content, short-form video and audience behaviors that have become more selective and less patient.
Seen this way, “Doctor Shin” is less a verdict on Im’s relevance than a case study in new market conditions. Her experimentation with a medical thriller did not translate into broad ratings success. That may reflect the difficulty of marrying her signature dramatic style to a genre with different audience expectations. It may also reflect the challenge of asking viewers to invest in a highly idiosyncratic premise at a time when they have endless alternatives. Neither explanation means the star writer is obsolete. It means the terms of power have changed.
The deeper question raised by her possible hiatus is what a sustainable next chapter for star writers might look like. Can they preserve the singularity that built their audience while collaborating in ways that reduce personal strain? Can the industry develop production models that protect distinctive voices without demanding total self-sacrifice? And can broadcasters and platforms learn to measure success using more than the bluntest metrics? Those are not abstract questions anymore. They are practical ones, and Im’s comments make them urgent.
Between the age of ratings and the age of fandom
Im reportedly said there is no need to become consumed by ratings numbers. In a traditional broadcast business, that might sound unrealistic. But in today’s Korean media landscape, it is closer to a challenge: What, exactly, counts as success now?
For decades, ratings served as the most visible and legible shorthand for a show’s health. They still matter in South Korea, particularly for broadcast and cable channels that rely on advertisers and need simple, immediate signals to justify programming decisions. But the media environment has outgrown any single measure. Viewers watch live, watch later, clip scenes for social media, debate episodes online, revisit series through streaming and build communities around works that may never have been mainstream blockbusters in the first place.
That is where fandom complicates the old math. Some dramas are made to appeal broadly and smoothly; others survive by being intensely specific. Im’s body of work has long belonged to the second category. Her stories do not necessarily invite universal approval. They encourage allegiance. For some viewers, that can be more durable than broad but shallow popularity. A show with modest conventional ratings may still produce fierce loyalty, sustained conversation and a longer cultural afterlife than a more broadly watched but quickly forgotten hit.
Korean pop culture has repeatedly shown how powerful such devoted followings can be. K-pop fans, for instance, have helped turn artists into global forces through coordinated digital activity, not just passive consumption. Television fandom is not identical, but the principle is similar: intensity can matter as much as scale. The challenge is that industry institutions often remain built around older metrics. Advertisers prefer clarity. Networks prefer comparability. Investors prefer hard numbers. Fandom is real, but it is harder to quantify neatly.
That leaves certain kinds of work vulnerable to underestimation. A sharply polarizing series may be judged too quickly as a failure because it did not produce a comfortably high rating, even if it generated a highly engaged audience with long-term value. At the same time, it would be naive to dismiss ratings altogether. They still affect budgets, renewals and talent decisions. The point is not that numbers do not matter. It is that they do not tell the whole story, especially for a writer whose cultural footprint has never fit cleanly inside a Nielsen-like frame.
Im’s comments, then, land at the intersection of two eras. One is the old broadcast order, where overnight performance was king. The other is the fragmented present, where audience attachment is scattered across platforms and timelines. Korean television is still trying to live in both worlds at once. “Doctor Shin” may be one of the latest examples of how awkward that transition can look.
What this moment says about the future of Korean drama
It would be easy to reduce this episode to a familiar entertainment-industry headline: veteran creator, disappointing ratings, talk of a hiatus. But that would miss the larger significance. Im Sung-han’s possible break matters because it exposes several pressures converging at once in Korean television: the fading simplicity of ratings, the strain placed on star creators, the challenge of building durable audiences in a fragmented market and the increasingly public cost of burnout.
For American viewers, Korean drama often arrives as a polished export — sleek, intense, emotionally precise and bingeable. What audiences abroad see is the finished product. What they see less clearly is the labor system behind it, one that has produced remarkable cultural output but may be reaching a point where its creative economics are harder to sustain. If one of the country’s most famous writers is saying she needs years away from drama, the industry should hear not just exhaustion but instruction.
That instruction is not necessarily that Korean drama must abandon its speed, ambition or emotional intensity. Those qualities are part of what made it globally influential in the first place. But an industry that depends on singular voices cannot afford to consume those voices until they break. If South Korea wants to keep producing the kind of television that captures viewers from Seoul to Seattle, it may need to rethink not only how it measures success, but how it protects the people expected to create it.
Im’s own career has always challenged easy interpretation. She has been celebrated, mocked, copied and argued over. Her shows have drawn both devotion and disbelief. In that sense, it is fitting that her latest headline should also resist a simple reading. This is not just the story of a writer taking a rest after a difficult project. It is the story of an industry being forced to ask itself whether the old bargain — total creative output in exchange for cultural power — still makes sense.
Whether Im returns quickly, shifts into a new format or stays away for years, her remarks have already done something significant: They have redirected attention from the product to the conditions of production. In any entertainment economy, that is an uncomfortable move. But it is often a necessary one. Korean drama has spent years asking audiences to keep watching, keep streaming and keep caring. Im Sung-han’s declaration asks a different question: Can the people making this work keep going like this? Right now, the answer appears less certain than the industry might like to admit.
0 Comments